Real lives. Real data. Real results.

At Elcella, we believe the best proof comes from real lives, not just numbers. That’s
why we ran a 12-week consumer trial - tracking weight, waistline, appetite,
cravings, energy, and daily habits. The results speak for themselves.

Elcella’s 12-Week Trial Proved
What Science Predicted

Clare, 52

Taking Elcella since May 2025

Lost 6.35kg and 18cm from her waistline
Reported improved gut symptoms
Built a healthier relationship with food and alcohol

“Losing centimetres from my waist had always been impossible for me. This was unheard of, I felt like I finally had control over my body. Elcella is a gamechanger!”

Sara, 51

Taking Elcella Awaken Since May ‘25

Active healthcare professional wanting to get back to her healthy set weight
Lost 10 Kilos in 24 weeks
Taking 4 capsules per day since Aug ‘25 -continues to drop kgs

“Thank you, ... I feel me again”

William, 63

Taking Elcella since May 2025

Lost 6.35kg
Reduced waistline from 180cm to 121cm
Dropped from 4XL trousers to XL

“I haven’t just lost weight – I’ve completely changed my shape and I’ve finally been able to have the knee surgery I needed.”

Will, 47

Taking Elcella since May 2025

Lost 19kg so far
Gained greater control around food and alcohol
Moved away from old unhealthy habits

“It made me disciplined. I have never been that regimented before. If I was out, I would take my Elcella capsules with me. Wherever I was, I stuck to my Elcella plan.”

Andrew, 54

Taking Elcella since May 2025

Lost 6.5kg so far
Reduced 8.9cm from his waistline
Enjoying greater control over his appetite

“Amazingly liberating having 3 1/2 inches less and all my clothes fit easier. It is just quite a crazy feeling to have that level of control.”

Science is Important to Us.

Built by leading gut neuroscientists and backed by over 15 years of research, Elcella aims to offer a pioneering world first - a new class of regenerative nutrition designed to retrain your biology, re-awaken and rebuild the gut ecosystem, and restore the body’s natural appetite intelligence and metabolic balance.

Inside Our 12‑Week Consumer Study

Why We Did It
The goal of our consumer trial was to show how Elcella works for people in everyday life. Over 12 weeks, participants tracked changes in weight, waist circumference, appetite, cravings, energy, and lifestyle habits. Our consumer trial followed over 3 years worth of clinical trials.

What We Measured
Weight and waist circumference and weekly surveys on appetite, cravings, energy, and lifestyle habits. Progress tracked at week 0, 4, 8, and 12 weeks.

What we tracked:

Weight change Food & Drink Cravings Self-confidence Waist
circumference change Food noise Energy Levels

Average Change in Body
Weight and Waist Circumference

Improved Appetite Control 94%

Reduced Food Noise 94%

Increased Post-Meal Fullness 88%

Reduced Hunger Between Meals 70%

Higher Energy Levels 76%

Improved Self-Confidence 76%

Increased Healthy Choices 88%

*Data from a consumer trial of 51 people, of which 34 completed 12 weeks of Elcella to clinical standards

Validation

Pre‑Clinical Research

Our pre-clinical work demonstrates that targeted nutrient delivery can activate specific colonic G-protein-coupled receptors (GPCRs), stimulating the natural release of key appetite-regulating gut hormones. This mechanism mimics the body’s post-meal response in a patented, nutrient-based way.

Our approach mimics the natural post-meal rise of these gut hormones in a novel, natural and patented approach.

Clinical Research

Our clinical findings indicate that a specific combination of medium and long chain fatty acids, precisely delivered to the colon, increases natural fullness signals (GLP-1 & PYY), helping explain why participants reported reduced appetite after use. These results support the potential of enhancing natural nutrient-signalling pathways to safely promote appetite control through the body’s own biology.

This result supports the idea that our approach, boosting natural nutrient signalling pathways, can support the body release its own appetite-lowering hormones in a targeted, and importantly, safe approach.

Our Scientists

Dr. Madusha Peiris, PhD

Founder & CEO

A world-leading expert in gut health with a PhD in Neuroscience

Dr. Madusha Peiris is a leading authority on gut hormones and appetite regulation, with over a decade of research on how the gut communicates with the brain to control hunger, weight, and metabolism. Her work bridges gut physiology, nutrition, and hormonal health, with a focus on obesity, clinical trials, and the gut–brain–hormone axis. Madusha is known for translating complex science into practical insights, especially for women navigating hormonal change, perimenopause, and weight management. She is also the founder and CEO of Elcella.

Dr. Rubina Aktar, PhD

Co-Founder & COO

A gut physiology specialist with a PhD in Neurogastroenterology

Dr. Ruby Aktar is a leading expert in gut–brain communication, with over 12 years of pioneering research at the Wingate Institute, Queen Mary University of London. She specialises in the enteric nervous system - the gut’s “second brain” - and how microbes and nutrients shape appetite, mood, and digestive health. Ruby’s work spans IBS, microbiota, and nutrient signalling, uncovering how gut-brain pathways drive conditions like disordered appetite and weight regulation. A recognised lecturer and international researcher, she brings world-class expertise and clarity to the science of how our gut influences the way we feel, eat, and live.

Combined expertise together: Dr Madusha Peiris & Dr Rubina Aktar have contributed to groundbreaking research in gut and neurogastroenterology, with expertise spanning laboratory, clinical, and translational science.

140+

Publications

Covering neuroscience, gut science,
neurogastroenterology, obesity, and neurochemistry.

31+

Awards & Research Grants

Recognised for excellence in Gastrointestinal
and Neurogastroenterology research,
innovation, and discovery.

8

Clinical Studies

Involving human studies exploring gut–brain
interactions, appetite regulation, microbiota, and
neurogastrointestinal function.

Real lives. Real data. Real results.